Hypermethylation of a 5' CpG island of p16 is a frequent event in non-Hodgkin's lymphoma

被引:73
作者
MartinezDelgado, B
FernandezPiqueras, J
Garcia, MJ
Arranz, E
Gallego, J
Rivas, C
Robledo, M
Benitez, J
机构
[1] FDN JIMENEZ DIAZ,DEPT PATHOL,E-28040 MADRID,SPAIN
[2] UNIV AUTONOMA MADRID,DEPT GENET,MADRID,SPAIN
关键词
methylation; p16; gene; non-Hodgkin lymphomas;
D O I
10.1038/sj.leu.2400579
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypermethylation of a 5' CpG island of p16 gene has been recently described as a possible way of inactivation of this tumor suppressor gene, alternative to deletions and mutations. We have investigated if hypermethylation of a 5' CpG island of pie occurs in non-Hodgkin's lymphoma (NHL) and normal lymphoid tissue. A total of 82 NHLs were examined for p16 methylation by Southern blot and PCR analysis. Hypermethylation was detected in approximately 20% of B cell lymphomas of both low and high grade and in 15% of T cell NHL. The highest rate of pie gene methylation in tumors was found among MALT (mucosa-associated lymphoid tissue) lymphomas in which the percentage of cases with p16 gene methylation reached 67%. However, normal lymphoid tissue was always unmethylated at p16 locus. These results indicate that p16 gene methylation is a frequent event in NHLs, mainly in MALT lymphomas, and suggest that it could be an important mechanism of inactivation of this gene.
引用
收藏
页码:425 / 428
页数:4
相关论文
共 25 条
  • [1] FREQUENT SOMATIC MUTATIONS AND HOMOZYGOUS DELETIONS OF THE P16 (MTS1) GENE IN PANCREATIC ADENOCARCINOMA
    CALDAS, C
    HAHN, SA
    DACOSTA, LT
    REDSTON, MS
    SCHUTTE, M
    SEYMOUR, AB
    WEINSTEIN, CL
    HRUBAN, RH
    YEO, CJ
    KERN, SE
    [J]. NATURE GENETICS, 1994, 8 (01) : 27 - 32
  • [2] DELMER A, 1995, LEUKEMIA, V9, P1240
  • [3] FERNANDEZPIQUER.J, IN PRESS CANC GENET
  • [4] DELETIONS OF THE CYCLIN-DEPENDENT KINASE INHIBITOR GENES P16(INK4A) AND P15(INK4B) IN NON-HODGKINS-LYMPHOMAS
    GOMBART, AF
    MOROSETTI, R
    MILLER, CW
    SAID, JW
    KOEFFLER, HP
    [J]. BLOOD, 1995, 86 (04) : 1534 - 1539
  • [5] GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531
  • [6] HERMAN JG, 1995, CANCER RES, V55, P4525
  • [7] GERMLINE P16 MUTATIONS IN FAMILIAL MELANOMA
    HUSSUSSIAN, CJ
    STRUEWING, JP
    GOLDSTEIN, AM
    HIGGINS, PAT
    ALLY, DS
    SHEAHAN, MD
    CLARK, WH
    TUCKER, MA
    DRACOPOLI, NC
    [J]. NATURE GENETICS, 1994, 8 (01) : 15 - 21
  • [8] Iolascon A, 1996, LEUKEMIA, V10, P255
  • [9] Jamal R, 1996, LEUKEMIA, V10, P629
  • [10] ANALYSIS OF THE P16 GENE (CDKN2) AS A CANDIDATE FOR THE CHROMOSOME 9P MELANOMA SUSCEPTIBILITY LOCUS
    KAMB, A
    SHATTUCKEIDENS, D
    EELES, R
    LIU, Q
    GRUIS, NA
    DING, W
    HUSSEY, C
    TRAN, T
    MIKI, Y
    WEAVERFELDHAUS, J
    MCCLURE, M
    AITKEN, JF
    ANDERSON, DE
    BERGMAN, W
    FRANTS, R
    GOLDGAR, DE
    GREEN, A
    MACLENNAN, R
    MARTIN, NG
    MEYER, LJ
    YOUL, P
    ZONE, JJ
    SKOLNICK, MH
    CANNONALBRIGHT, LA
    [J]. NATURE GENETICS, 1994, 8 (01) : 22 - 26